Structure Based Modeling of Small Molecules Binding to the TLR7 by Atomistic Level Simulations

Area of Science:

• Immunology
• Computational Biology
• Drug Discovery

Background:

• Toll-Like Receptors (TLR) are crucial immune system proteins with therapeutic potential in viral diseases and cancer.
• Targeting Toll-Like Receptor 7 (TLR7) is a promising strategy for developing novel immunomodulatory drugs.
• Understanding TLR7 agonist interactions is key for designing effective therapeutic compounds.

Purpose of the Study:

• To investigate the interaction mechanism between Toll-Like Receptor 7 (TLR7) and key agonist classes (imidazoquinoline and adenine derivatives).
• To develop a computational model for the dimeric form of TLR7 to facilitate in silico analysis.
• To identify qualitative and quantitative differences between active and inactive TLR7 ligands.

Main Methods:

• Utilized molecular docking and Molecular Dynamics simulations for computational analysis.
• Developed a novel computational model representing the dimeric form of Toll-Like Receptor 7 (TLR7).
• Compared in silico findings with existing experimental data to validate results.

Main Results:

• Established a detailed understanding of the ligand binding mechanism for Toll-Like Receptor 7 (TLR7).
• Differentiated between active agonists and inactive compounds based on computational analysis.
• Provided insights into the specific interactions governing TLR7 activation by imidazoquinoline and adenine derivatives.

Conclusions:

• The study defines the molecular interactions underlying TLR7 agonism, offering valuable data for drug design.
• Computational modeling of the TLR7 dimer provides a new tool for future drug discovery efforts.
• Findings support the development of targeted TLR7 agonists for treating viral pathologies and cancer.